KCM
Kynam Capital Management’s Sutro Biopharma STRO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.63M | Sell |
5,088,099
-353,348
| -6% | -$252K | 0.39% | 25 |
|
2025
Q1 | $3.54M | Buy |
5,441,447
+1,800,000
| +49% | +$1.17M | 0.3% | 26 |
|
2024
Q4 | $6.7M | Buy |
3,641,447
+1,575,000
| +76% | +$2.9M | 0.4% | 23 |
|
2024
Q3 | $7.15M | Buy |
2,066,447
+42,764
| +2% | +$148K | 0.55% | 21 |
|
2024
Q2 | $5.93M | Buy |
2,023,683
+21,956
| +1% | +$64.3K | 0.46% | 19 |
|
2024
Q1 | $11.3M | Hold |
2,001,727
| – | – | 1.18% | 15 |
|
2023
Q4 | $8.59M | Buy |
2,001,727
+449,052
| +29% | +$1.93M | 0.95% | 19 |
|
2023
Q3 | $5.39M | Buy |
1,552,675
+52,675
| +4% | +$183K | 0.88% | 19 |
|
2023
Q2 | $6.98M | Buy |
1,500,000
+598,164
| +66% | +$2.78M | 0.96% | 17 |
|
2023
Q1 | $4.17M | Buy |
901,836
+497,292
| +123% | +$2.3M | 0.54% | 24 |
|
2022
Q4 | $3.27M | Buy |
+404,544
| New | +$3.27M | 0.5% | 23 |
|